FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Simon Hawke

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Mouse

Procedures

Phenomena

Glycosylation

Concepts & Ideas

Protein Conformation

Anatomy

Co-author Network

Publications

TOP 3
MOURAD TAYEBI; Monique David; Clive Bate; Daryl Jones; William Taylor; Rebecca Morton; John Pollard; Simon Hawke
Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis.
MOURAD TAYEBI; John Collinge; Simon Hawke
Unswitched immunoglobulin M response prolongs mouse survival in prion disease.
Azadeh Khalili-Shirazi; Maria Kaisar; Gary Mallinson; Samantha Jones; Daljit Bhelt; Carol Fraser; Anthony R Clarke; Simon Hawke; Graham S Jackson; John Collinge
Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Simon Hawke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: MOURAD TAYEBI; Monique David; Clive Bate; Daryl Jones; William Taylor; Rebecca Morton; John Pollard; Simon Hawke
Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis.
The Journal of general virology 2010;91(Pt 12):3105-15.
2009: MOURAD TAYEBI; John Collinge; Simon Hawke
Unswitched immunoglobulin M response prolongs mouse survival in prion disease.
The Journal of general virology 2009;90(Pt 3):777-82.
2007: Azadeh Khalili-Shirazi; Maria Kaisar; Gary Mallinson; Samantha Jones; Daljit Bhelt; Carol Fraser; Anthony R Clarke; Simon Hawke; Graham S Jackson; John Collinge
Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
Biochimica et biophysica acta 2007;1774(11):1438-50.
2007: MOURAD TAYEBI; Clive Bate; Simon Hawke; Alun Williams
A role for B lymphocytes in anti-infective prion therapies?
Expert review of anti-infective therapy 2007;5(4):631-8.
2006: MOURAD TAYEBI; Simon Hawke
Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
Immunology letters 2006;105(2):123-6.
2005: Azadeh Khalili-Shirazi; Linda Summers; Jacqueline M Linehan; Gary Mallinson; David J Anstee; Simon Hawke; Graham S Jackson; John Collinge
PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
The Journal of general virology 2005;86(Pt 9):2635-44.
2005: Azadeh Khalili-Shirazi; Sonia Quaratino; Marco Londei; Linda Summers; MOURAD TAYEBI; Anthony R Clarke; Simon Hawke; Graham S Jackson; John Collinge
Protein conformation significantly influences immune responses to prion protein.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3256-63.
2004: Vincent Beringue; Didier Vilette; Gary Mallinson; Fabienne Archer; Maria Kaisar; MOURAD TAYEBI; Graham S Jackson; Anthony R Clarke; Hubert Laude; John Collinge; Simon Hawke
PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.
The Journal of biological chemistry 2004;279(38):39671-6.
2004: MOURAD TAYEBI; Perry Enever; Zahid Sattar; John Collinge; Simon Hawke
Disease-associated prion protein elicits immunoglobulin M responses in vivo.
Molecular medicine (Cambridge, Mass.) 2004;10(7-12):104-11.
2003: Vincent Beringue; Gary Mallinson; Maria Kaisar; MOURAD TAYEBI; Zahid Sattar; Graham Jackson; David J Anstee; John Collinge; Simon Hawke
Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
Brain : a journal of neurology 2003;126(Pt 9):2065-73.
2003: Anthony R White; Perry Enever; MOURAD TAYEBI; Rosey Mushens; Jacqueline M Linehan; Sebastian Brandner; David J Anstee; John Collinge; Simon Hawke
Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
Nature 2003;422(6927):80-3.
2003: Tonia L Vincent; Mark P Richardson; Charles G Mackworth-Young; Simon Hawke; Patrick J W Venables
Sjögren's syndrome-associated myelopathy: response to immunosuppressive treatment.
The American journal of medicine 2003;114(2):145-8.